跳至主要内容
临床试验/NCT01482260
NCT01482260
已完成
不适用

Comparative Microarray Analysis of microRNA Expression Profiles in Primary Cutaneous Malignant Melanoma, Cutaneous Malignant Melanoma Metastases and Benign Melanocytic Naevi

Ruhr University of Bochum1 个研究点 分布在 1 个国家目标入组 21 人2011年12月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cutaneous Malignant Melanoma
发起方
Ruhr University of Bochum
入组人数
21
试验地点
1
状态
已完成
最后更新
13年前

概览

简要总结

Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). This study will be an exploratory analysis by miRNA expression profiling using microarrays.

详细描述

Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). With regards to a rapidly growing number of newly discovered miRNA sequences, the availability of up-to-date miRNA expression profiles for primary cutaneous malignant melanoma (PCMM), cutaneous malignant melanoma metastases (CMMM) and benign melanocytic naevi (BMN) is limited. Patients with PCMM, CMMM and BMN are included in the study to perform an exploratory analysis by miRNA expression profiling using microarrays. Expression levels of miRNA candidates will be validated by TaqMan real-time quantitative polymerase chain reaction (RT-PCR).

注册库
clinicaltrials.gov
开始日期
2011年12月
结束日期
2012年1月
最后更新
13年前
研究类型
Observational
性别
All

研究者

发起方
Ruhr University of Bochum
责任方
Principal Investigator
主要研究者

Michael Sand

Principal Investigator

Ruhr University of Bochum

入排标准

入选标准

  • Primary Cutaneous Malignant Melanoma
  • Cutaneous Malignant Melanoma Metastases
  • Benign Melanocytic Naevi

排除标准

  • Other Skin Cancer than Primary Cutaneous Malignant Melanoma

结局指标

主要结局

未指定

研究点 (1)

Loading locations...

相似试验